ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,008.94
0.70%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cellect Biotechnology Ltd (APOP)

  7. Cellect Biotechnology Ltd (APOP) Noticias

APOP

Cellect Biotechnology (APOP)

Cellect Biotechnology Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:APOP
FechaHoraFuenteTítuloSímboloCompañía
28/06/202314:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/06/202314:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
09/05/202314:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APOPCellect Biotechnology Ltd
20/03/202305:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
15/03/202313:40Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APOPCellect Biotechnology Ltd
03/03/202315:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
23/02/202305:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:APOPCellect Biotechnology Ltd
14/02/202313:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
09/02/202305:05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/02/202305:03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202308:48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202210:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
31/08/202206:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:APOPCellect Biotechnology Ltd
04/08/202210:45Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/08/202205:04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:APOPCellect Biotechnology Ltd
30/06/202215:58Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APOPCellect Biotechnology Ltd
14/06/202216:16Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:APOPCellect Biotechnology Ltd
14/04/202205:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:APOPCellect Biotechnology Ltd
15/10/202115:01GlobeNewswire Inc.Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
27/09/202108:10GlobeNewswire Inc.Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
02/09/202115:20GlobeNewswire Inc.Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.NASDAQ:APOPCellect Biotechnology Ltd
24/08/202115:16GlobeNewswire Inc.Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating ResultsNASDAQ:APOPCellect Biotechnology Ltd
13/08/202115:20GlobeNewswire Inc.The Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin PharmaceuticalsNASDAQ:APOPCellect Biotechnology Ltd
03/08/202115:29Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:APOPCellect Biotechnology Ltd
16/06/202117:58GlobeNewswire Inc.Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmace...NASDAQ:APOPCellect Biotechnology Ltd
19/04/202107:00GlobeNewswire Inc.Cellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical TrialNASDAQ:APOPCellect Biotechnology Ltd
29/03/202108:29GlobeNewswire Inc.Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating ResultsNASDAQ:APOPCellect Biotechnology Ltd
24/03/202116:26GlobeNewswire Inc.Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic MergerNASDAQ:APOPCellect Biotechnology Ltd
11/02/202110:52Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:APOPCellect Biotechnology Ltd
20/11/202007:00GlobeNewswire Inc.Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelera...NASDAQ:APOPCellect Biotechnology Ltd
 Showing the most relevant articles for your search:NASDAQ:APOP

Su Consulta Reciente

SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURMXN
Euro vs MXN
NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
CCOM
OILBRENT
Brent Oil
USI
USTECH100
US Tech 100
CCOM
US30
US 30
PM
XAUUSD
Gold vs US Dollar
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados